nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—ALB—Vandetanib—thyroid cancer	0.373	0.498	CbGbCtD
MACITENTAN—CYP2C19—Sorafenib—thyroid cancer	0.146	0.195	CbGbCtD
MACITENTAN—CYP3A4—Vandetanib—thyroid cancer	0.117	0.156	CbGbCtD
MACITENTAN—CYP3A4—Sorafenib—thyroid cancer	0.0705	0.0941	CbGbCtD
MACITENTAN—CYP3A4—Doxorubicin—thyroid cancer	0.0428	0.0571	CbGbCtD
MACITENTAN—EDNRB—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.023	0.134	CbGpPWpGaD
MACITENTAN—EDNRA—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.0165	0.0957	CbGpPWpGaD
MACITENTAN—EDNRB—Endothelin Pathways—CALCA—thyroid cancer	0.00917	0.0532	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelin Pathways—CALCA—thyroid cancer	0.00657	0.0381	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide GPCRs—TSHR—thyroid cancer	0.00642	0.0373	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide GPCRs—TSHR—thyroid cancer	0.0046	0.0267	CbGpPWpGaD
MACITENTAN—Nasopharyngitis—Vandetanib—thyroid cancer	0.00451	0.0576	CcSEcCtD
MACITENTAN—EDNRA—EGFR-dependent Endothelin signaling events—HRAS—thyroid cancer	0.00441	0.0256	CbGpPWpGaD
MACITENTAN—Influenza—Vandetanib—thyroid cancer	0.00436	0.0557	CcSEcCtD
MACITENTAN—Bronchitis—Vandetanib—thyroid cancer	0.00419	0.0536	CcSEcCtD
MACITENTAN—EDNRB—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.00413	0.024	CbGpPWpGaD
MACITENTAN—Infestation—Vandetanib—thyroid cancer	0.00389	0.0497	CcSEcCtD
MACITENTAN—Infestation NOS—Vandetanib—thyroid cancer	0.00389	0.0497	CcSEcCtD
MACITENTAN—Urinary tract infection—Vandetanib—thyroid cancer	0.00378	0.0483	CcSEcCtD
MACITENTAN—EDNRB—GPCR ligand binding—CALCB—thyroid cancer	0.00333	0.0193	CbGpPWpGaD
MACITENTAN—Angiopathy—Vandetanib—thyroid cancer	0.00317	0.0404	CcSEcCtD
MACITENTAN—Nasopharyngitis—Sorafenib—thyroid cancer	0.00304	0.0389	CcSEcCtD
MACITENTAN—EDNRA—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.00296	0.0172	CbGpPWpGaD
MACITENTAN—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.00284	0.0165	CbGpPWpGaD
MACITENTAN—Infestation—Sorafenib—thyroid cancer	0.00262	0.0335	CcSEcCtD
MACITENTAN—Infestation NOS—Sorafenib—thyroid cancer	0.00262	0.0335	CcSEcCtD
MACITENTAN—ALB—Recycling of bile acids and salts—RXRA—thyroid cancer	0.00259	0.015	CbGpPWpGaD
MACITENTAN—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00258	0.015	CbGpPWpGaD
MACITENTAN—Oedema—Vandetanib—thyroid cancer	0.00248	0.0317	CcSEcCtD
MACITENTAN—Infection—Vandetanib—thyroid cancer	0.00246	0.0315	CcSEcCtD
MACITENTAN—Nervous system disorder—Vandetanib—thyroid cancer	0.00243	0.0311	CcSEcCtD
MACITENTAN—EDNRA—GPCR ligand binding—CALCB—thyroid cancer	0.00239	0.0138	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—SST—thyroid cancer	0.00235	0.0136	CbGpPWpGaD
MACITENTAN—Angiopathy—Sorafenib—thyroid cancer	0.00214	0.0273	CcSEcCtD
MACITENTAN—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.00203	0.0118	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.00203	0.0118	CbGpPWpGaD
MACITENTAN—Anaemia—Sorafenib—thyroid cancer	0.00189	0.0242	CcSEcCtD
MACITENTAN—EDNRB—GPCR downstream signaling—CALCB—thyroid cancer	0.00188	0.0109	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—CDK1—thyroid cancer	0.00185	0.0108	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CALCB—thyroid cancer	0.00171	0.00993	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—SST—thyroid cancer	0.00168	0.00976	CbGpPWpGaD
MACITENTAN—Infection—Sorafenib—thyroid cancer	0.00166	0.0212	CcSEcCtD
MACITENTAN—Fluid retention—Epirubicin—thyroid cancer	0.00165	0.021	CcSEcCtD
MACITENTAN—Nervous system disorder—Sorafenib—thyroid cancer	0.00164	0.021	CcSEcCtD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.00158	0.00915	CbGpPWpGaD
MACITENTAN—Headache—Vandetanib—thyroid cancer	0.00155	0.0198	CcSEcCtD
MACITENTAN—EDNRB—GPCR ligand binding—TSHR—thyroid cancer	0.00154	0.00896	CbGpPWpGaD
MACITENTAN—Fluid retention—Doxorubicin—thyroid cancer	0.00152	0.0194	CcSEcCtD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.00145	0.00842	CbGpPWpGaD
MACITENTAN—ALB—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.00135	0.00785	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CALCB—thyroid cancer	0.00135	0.00782	CbGpPWpGaD
MACITENTAN—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00133	0.00774	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—CDK1—thyroid cancer	0.00133	0.0077	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—PTCH1—thyroid cancer	0.00131	0.00761	CbGpPWpGaD
MACITENTAN—EDNRB—Endothelins—HRAS—thyroid cancer	0.0013	0.00754	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CALCB—thyroid cancer	0.00122	0.0071	CbGpPWpGaD
MACITENTAN—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.00122	0.00707	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—SST—thyroid cancer	0.0012	0.00696	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.00118	0.00683	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CALCA—thyroid cancer	0.00116	0.0067	CbGpPWpGaD
MACITENTAN—EDNRB—Endothelins—AKT1—thyroid cancer	0.00115	0.00666	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.00113	0.00655	CbGpPWpGaD
MACITENTAN—Nasopharyngitis—Epirubicin—thyroid cancer	0.00112	0.0144	CcSEcCtD
MACITENTAN—EDNRA—GPCR ligand binding—TSHR—thyroid cancer	0.0011	0.00641	CbGpPWpGaD
MACITENTAN—Influenza—Epirubicin—thyroid cancer	0.00109	0.0139	CcSEcCtD
MACITENTAN—Headache—Sorafenib—thyroid cancer	0.00105	0.0134	CcSEcCtD
MACITENTAN—Bronchitis—Epirubicin—thyroid cancer	0.00105	0.0134	CcSEcCtD
MACITENTAN—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00104	0.0133	CcSEcCtD
MACITENTAN—EDNRB—Signaling Pathways—CALCB—thyroid cancer	0.00101	0.00586	CbGpPWpGaD
MACITENTAN—Influenza—Doxorubicin—thyroid cancer	0.00101	0.0128	CcSEcCtD
MACITENTAN—Infestation NOS—Epirubicin—thyroid cancer	0.000969	0.0124	CcSEcCtD
MACITENTAN—Infestation—Epirubicin—thyroid cancer	0.000969	0.0124	CcSEcCtD
MACITENTAN—Bronchitis—Doxorubicin—thyroid cancer	0.000967	0.0124	CcSEcCtD
MACITENTAN—EDNRB—Signaling Pathways—TRIM33—thyroid cancer	0.000958	0.00556	CbGpPWpGaD
MACITENTAN—Urinary tract infection—Epirubicin—thyroid cancer	0.000942	0.012	CcSEcCtD
MACITENTAN—EDNRA—GPCR ligand binding—PTCH1—thyroid cancer	0.000939	0.00545	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelins—HRAS—thyroid cancer	0.00093	0.0054	CbGpPWpGaD
MACITENTAN—Infestation NOS—Doxorubicin—thyroid cancer	0.000897	0.0115	CcSEcCtD
MACITENTAN—Infestation—Doxorubicin—thyroid cancer	0.000897	0.0115	CcSEcCtD
MACITENTAN—EDNRB—GPCR downstream signaling—TSHR—thyroid cancer	0.000872	0.00506	CbGpPWpGaD
MACITENTAN—Urinary tract infection—Doxorubicin—thyroid cancer	0.000872	0.0111	CcSEcCtD
MACITENTAN—Pharyngitis—Epirubicin—thyroid cancer	0.000864	0.011	CcSEcCtD
MACITENTAN—EDNRA—GPCR ligand binding—SST—thyroid cancer	0.000859	0.00498	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CALCA—thyroid cancer	0.000827	0.0048	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelins—AKT1—thyroid cancer	0.000821	0.00476	CbGpPWpGaD
MACITENTAN—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000807	0.00468	CbGpPWpGaD
MACITENTAN—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000802	0.00466	CbGpPWpGaD
MACITENTAN—Pharyngitis—Doxorubicin—thyroid cancer	0.000799	0.0102	CcSEcCtD
MACITENTAN—EDNRB—Signaling by GPCR—TSHR—thyroid cancer	0.000792	0.0046	CbGpPWpGaD
MACITENTAN—Angiopathy—Epirubicin—thyroid cancer	0.00079	0.0101	CcSEcCtD
MACITENTAN—EDNRB—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000779	0.00452	CbGpPWpGaD
MACITENTAN—Angiopathy—Doxorubicin—thyroid cancer	0.000731	0.00933	CcSEcCtD
MACITENTAN—EDNRA—Signaling Pathways—CALCB—thyroid cancer	0.000723	0.0042	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000708	0.00411	CbGpPWpGaD
MACITENTAN—Anaemia—Epirubicin—thyroid cancer	0.0007	0.00894	CcSEcCtD
MACITENTAN—EDNRA—Signaling Pathways—TRIM33—thyroid cancer	0.000686	0.00398	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—SST—thyroid cancer	0.000678	0.00394	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—PTCH1—thyroid cancer	0.000673	0.00391	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000665	0.00386	CbGpPWpGaD
MACITENTAN—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000654	0.0038	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CALCA—thyroid cancer	0.000653	0.00379	CbGpPWpGaD
MACITENTAN—Anaemia—Doxorubicin—thyroid cancer	0.000648	0.00827	CcSEcCtD
MACITENTAN—EDNRB—Signaling Pathways—TCF7L1—thyroid cancer	0.000639	0.00371	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—TSHR—thyroid cancer	0.000624	0.00362	CbGpPWpGaD
MACITENTAN—Oedema—Epirubicin—thyroid cancer	0.000618	0.0079	CcSEcCtD
MACITENTAN—EDNRB—Signaling by GPCR—SST—thyroid cancer	0.000616	0.00357	CbGpPWpGaD
MACITENTAN—Infection—Epirubicin—thyroid cancer	0.000614	0.00784	CcSEcCtD
MACITENTAN—Nervous system disorder—Epirubicin—thyroid cancer	0.000606	0.00774	CcSEcCtD
MACITENTAN—EDNRB—Signaling by GPCR—CALCA—thyroid cancer	0.000593	0.00344	CbGpPWpGaD
MACITENTAN—Hypotension—Epirubicin—thyroid cancer	0.000578	0.00738	CcSEcCtD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000572	0.00332	CbGpPWpGaD
MACITENTAN—Oedema—Doxorubicin—thyroid cancer	0.000572	0.00731	CcSEcCtD
MACITENTAN—Infection—Doxorubicin—thyroid cancer	0.000568	0.00726	CcSEcCtD
MACITENTAN—EDNRA—Signaling by GPCR—TSHR—thyroid cancer	0.000567	0.00329	CbGpPWpGaD
MACITENTAN—Nervous system disorder—Doxorubicin—thyroid cancer	0.000561	0.00716	CcSEcCtD
MACITENTAN—EDNRA—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000558	0.00324	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CDK1—thyroid cancer	0.000537	0.00311	CbGpPWpGaD
MACITENTAN—Hypotension—Doxorubicin—thyroid cancer	0.000535	0.00683	CcSEcCtD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000487	0.00282	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—SST—thyroid cancer	0.000485	0.00282	CbGpPWpGaD
MACITENTAN—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000485	0.00282	CbGpPWpGaD
MACITENTAN—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000483	0.0028	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PTCH1—thyroid cancer	0.000482	0.0028	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000476	0.00276	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TSHR—thyroid cancer	0.000468	0.00271	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CALCA—thyroid cancer	0.000467	0.00271	CbGpPWpGaD
MACITENTAN—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000464	0.00269	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PRKAR1A—thyroid cancer	0.00046	0.00267	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TCF7L1—thyroid cancer	0.000457	0.00265	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000442	0.00257	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000442	0.00257	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—SST—thyroid cancer	0.000441	0.00256	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MEN1—thyroid cancer	0.00044	0.00255	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CALCA—thyroid cancer	0.000424	0.00246	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000411	0.00239	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.00041	0.00238	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PTCH1—thyroid cancer	0.000398	0.00231	CbGpPWpGaD
MACITENTAN—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000393	0.00228	CbGpPWpGaD
MACITENTAN—Headache—Epirubicin—thyroid cancer	0.000387	0.00495	CcSEcCtD
MACITENTAN—EDNRA—Signaling by GPCR—CDK1—thyroid cancer	0.000384	0.00223	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000369	0.00214	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—SST—thyroid cancer	0.000364	0.00211	CbGpPWpGaD
MACITENTAN—Headache—Doxorubicin—thyroid cancer	0.000358	0.00458	CcSEcCtD
MACITENTAN—EDNRB—Signaling Pathways—CALCA—thyroid cancer	0.00035	0.00203	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000348	0.00202	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—RXRA—thyroid cancer	0.000347	0.00202	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TSHR—thyroid cancer	0.000335	0.00194	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000331	0.00192	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PRKAR1A—thyroid cancer	0.000329	0.00191	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000329	0.00191	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CDK1—thyroid cancer	0.000317	0.00184	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MEN1—thyroid cancer	0.000315	0.00183	CbGpPWpGaD
MACITENTAN—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.000288	0.00167	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PTCH1—thyroid cancer	0.000285	0.00165	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—MINPP1—thyroid cancer	0.000284	0.00165	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SST—thyroid cancer	0.00026	0.00151	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PRKAR1A—thyroid cancer	0.000255	0.00148	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—MINPP1—thyroid cancer	0.000255	0.00148	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NRG1—thyroid cancer	0.000254	0.00148	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CALCA—thyroid cancer	0.000251	0.00145	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—TP53—thyroid cancer	0.000246	0.00143	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—NDUFA13—thyroid cancer	0.000242	0.0014	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TERT—thyroid cancer	0.000228	0.00133	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CHST14—thyroid cancer	0.000227	0.00132	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CDK1—thyroid cancer	0.000227	0.00132	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000225	0.0013	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	0.000225	0.0013	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000221	0.00128	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—HIF1A—thyroid cancer	0.000218	0.00127	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—NDUFA13—thyroid cancer	0.000217	0.00126	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—RXRA—thyroid cancer	0.000209	0.00121	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CHST14—thyroid cancer	0.000204	0.00118	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—NRAS—thyroid cancer	0.000192	0.00112	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—HPGD—thyroid cancer	0.000183	0.00106	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NRG1—thyroid cancer	0.000182	0.00106	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—BRAF—thyroid cancer	0.000181	0.00105	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IFNA2—thyroid cancer	0.000169	0.000982	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000168	0.000976	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—KRAS—thyroid cancer	0.000166	0.000961	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—HPGD—thyroid cancer	0.000164	0.000955	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TERT—thyroid cancer	0.000163	0.000949	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HIF1A—thyroid cancer	0.000156	0.000907	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—MINPP1—thyroid cancer	0.000153	0.000891	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000149	0.000863	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000141	0.00082	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—HRAS—thyroid cancer	0.000141	0.000817	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—NRAS—thyroid cancer	0.000138	0.000799	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—AKT1—thyroid cancer	0.000137	0.000795	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000133	0.000774	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCND1—thyroid cancer	0.000132	0.000766	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—NDUFA13—thyroid cancer	0.000131	0.000757	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—BRAF—thyroid cancer	0.000129	0.000751	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PTEN—thyroid cancer	0.000127	0.00074	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—AKT1—thyroid cancer	0.000124	0.000722	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CHST14—thyroid cancer	0.000123	0.000712	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—KRAS—thyroid cancer	0.000119	0.000688	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NRAS—thyroid cancer	0.000114	0.00066	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—TPR—thyroid cancer	0.000105	0.000611	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PRKAR1A—thyroid cancer	0.000104	0.000601	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—HRAS—thyroid cancer	0.000101	0.000585	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—HPGD—thyroid cancer	9.89e-05	0.000574	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—AKT1—thyroid cancer	9.8e-05	0.000569	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—KRAS—thyroid cancer	9.79e-05	0.000568	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCND1—thyroid cancer	9.45e-05	0.000548	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—TPR—thyroid cancer	9.45e-05	0.000548	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.38e-05	0.000545	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	9.29e-05	0.000539	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PTEN—thyroid cancer	9.12e-05	0.000529	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—AKT1—thyroid cancer	8.9e-05	0.000516	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TP53—thyroid cancer	8.7e-05	0.000505	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.42e-05	0.000489	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—HRAS—thyroid cancer	8.32e-05	0.000483	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NRAS—thyroid cancer	8.14e-05	0.000472	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	7.91e-05	0.000459	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SLC5A5—thyroid cancer	7.88e-05	0.000457	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.38e-05	0.000428	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—AKT1—thyroid cancer	7.34e-05	0.000426	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SLC5A5—thyroid cancer	7.07e-05	0.00041	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—KRAS—thyroid cancer	7e-05	0.000406	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.63e-05	0.000385	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—RXRA—thyroid cancer	6.62e-05	0.000384	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.44e-05	0.000374	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—NRAS—thyroid cancer	6.31e-05	0.000366	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TP53—thyroid cancer	6.22e-05	0.000361	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HRAS—thyroid cancer	5.95e-05	0.000345	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—RXRA—thyroid cancer	5.94e-05	0.000345	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.78e-05	0.000335	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—TPR—thyroid cancer	5.68e-05	0.00033	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	5.59e-05	0.000324	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—KRAS—thyroid cancer	5.43e-05	0.000315	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—AKT1—thyroid cancer	5.26e-05	0.000305	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TP53—thyroid cancer	4.83e-05	0.00028	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—HRAS—thyroid cancer	4.62e-05	0.000268	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SLC5A5—thyroid cancer	4.25e-05	0.000247	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PPARG—thyroid cancer	4.18e-05	0.000243	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—AKT1—thyroid cancer	4.08e-05	0.000237	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PPARG—thyroid cancer	3.75e-05	0.000218	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—RXRA—thyroid cancer	3.57e-05	0.000207	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PTGS2—thyroid cancer	3.29e-05	0.000191	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PTGS2—thyroid cancer	2.95e-05	0.000171	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PTEN—thyroid cancer	2.87e-05	0.000166	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PTEN—thyroid cancer	2.57e-05	0.000149	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PPARG—thyroid cancer	2.26e-05	0.000131	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.77e-05	0.000103	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—AKT1—thyroid cancer	1.65e-05	9.59e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PTEN—thyroid cancer	1.55e-05	8.98e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—AKT1—thyroid cancer	1.48e-05	8.61e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—AKT1—thyroid cancer	8.92e-06	5.18e-05	CbGpPWpGaD
